References
- Hajjeh R. Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent Haemopphilus influenzae type b vaccine experience. Phil Trans R Soc B 2011;366:2827-32
- Munira S, Fritzen S. What influences government adoption of vaccines in developing countries? a policy process analysis. Soc Sci Med 2007;65:1751-64
- Hajjeh RA, Privor-Dumm L, Edmond K, et al. Supporting new vaccine introduction decisions: lessons learned from the Hib initiative experience. Vaccine 2010;28:7123-9
- GAVI Alliance. Rotavirus vaccine support. Available from: www.gavialliance.org/support/nvs/rotavirus/
- Soenarto Y, Aman AT, Bakri A, et al. Burden of severe rotavirus diarrhea in Indonesia. J Infect Dis 2009;200:S188-94
- WHO. Rotavirus vaccines WHO position paper: january 2013 – Recommendations. Vaccine 2013;31:6170-1
- Phua KB, Lim FS, Lau YL, et al. Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: a randomized clinical trial in an Asian population. Vaccine 2012;30:4552-7
- Zaman K, Anh DD, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomized, double-blind, placebo-controlled trial. Lancet 2010;376:615-23
- Wilopo SA, Kilgore P, Kosen S, et al. Economic evaluation of a routine rotavirus vaccination programme in Indonesia. Vaccine 2009;27S:F67-74
- Suwantika AA, Tu HT, Postma MJ. Cost-effectiveness of rotavirus immunization in Indonesia: taking breastfeeding patterns into account. Vaccine 2013;31(32):3300-7
- Nelson EAS, de Quadros CA, Santosham M, et al. Overcoming perceptions of financial barriers to rotavirus vaccine introduction in Asia. Hum Vaccin 2013;9(11):2418-26
- PATH. Country national immunization program (NIP), introduction of rotavirus vaccine. Available from: http://sites.path.org/rotavirusvaccine/rotavirus-advocacy-and-communications-toolkit/country-introduction-maps-and-list/
- GAVI Alliance. Accelerated vaccine introduction (AVI), report on the mapping and costing of activities. GAVI 2008;1-56
- McGuire TG. Setting prices for new vaccines (in advance). Int J Health Care Finance Econ 2003;3:207-74
- Dowdle WR, Orenstein WA. Quest for life-long protection by vaccination. Proc Natl Acad Sci USA 1994;91:2464-8
- GAVI Alliance. Vaccines boost economic growth in poorest countries. Available from: www.gavialliance.org/library/news/roi/2010/vaccines-boost-economic-growth-in-poorest-countries/
- WHO. Impact of new vaccines introduction on immunization and health systems. Available from: www.who.int/immunization/sage/NUVI_IS_HS_final_Refs_12_April_2010.pdf
- Dietz VJ, Lewin M, Zell E, Rodewald L. Evaluation of failure to follow vaccination recommendations as a marker for failure to follow other health recommendations. Pediatr Infect Dis J 1997;16(12):1157-61
- Clements CJ, Morgan C, Posanai E, et al. A qualitative evaluation of the immunization program in Papua New Guinea. PNG Med J 2006;49(1-2):5-13
- Clements DA. Cost of treatment and prevention of Haemophilus influenzae type b disease. An international perspective. Pharmacoeconomics 1994;6(5):442-52
- GAVI Alliance. Republic of Indonesia, application for support to immunization services and new and under-used vaccines. GAVI 2008;10-11
- Lydon P, Levine R, Makinen M. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability? Vaccine 2008;26:6706-16
- Levine OS, Cherian T, Shah R, Batson A. PneumoADIP: an example of translational research to accelerate pneumococcal vaccination in developing countries. J Health Popul Nutr 2004;22(3):268-74
- Results for Development Institute. Synthesis report: new vaccine adoption in lower-middle-income countries. Results for Development Institute; 2011. p. 1-101
- USAID. Improving child health in Indonesia, Indonesia immunization project, BASICS III. Available from: www.basics.org/reports/FinalReport/Indonesia_TO1_Final_Report_BASICS.pdf
- WHO. WHO-UNICEF guidelines for developing a comprehensive multi-year plan (cMYP). Available from: whqlibdoc.who.int/hq/2005/WHO_IVB_05.20_eng.pdf
- WHO. Immunization financing toolkit, a resource for policy-makers and program managers. Available from: www.who.int/immunization_financing/tools/final_toolkit_2011.pdf
- GAVI Alliance. Ensuring there is “fiscal space’’ to finance immunization and vaccination programs. Available from: www.gavialliance.org/library/pf2012-sessions/28-–-gavi-graduation--achieve,-share,-inspire/
- Lieu TA, McGuire TG, Hinman AR. Overcoming economic barriers to the optimal use of vaccines. Health Aff 2005;24(3):666-79
- Wilson P. Giving developing countries the best shot: an overview of vaccine access and R&D. Oxfam International, Geneva, Switzerland; 2010. p. 1-28
- Tu HAT, Rozenbaum MH, Coyte PC, et al. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries. Vaccine 2012;30:1521-8
- The World Bank. Inflation, consumer prices (annual, %). Available from: http://data.worldbank.org/indicator/NY.GDP.DEFL.KD.ZG
- Kang G. Rotavirus vaccines. Indian J Med Microbiol 2006;24(4):252-7
- Bhan A, Green SK. Balancing safety, efficacy and cost: improving rotavirus vaccine adoption in low- and middle-income countries. Journal of Global Health 2011;1(2):148-53
- SABIN. RV3 Rotavirus Vaccine: A human neonatal rotavirus vaccine to protect against rotavirus disease from birth. Available from: http://www.sabin.org/sites/sabin.org/files/Julie%20Bines%20RV3_web.pdf
- MCRI. Indonesian launch of rotavirus vaccine trial. Available from: www.mcri.edu.au/news/2013/march/rotavirus/
- Hyde TB, Dentz H, Wang SA, et al. The impact of new vaccine introduction on immunization and health systems: a review of the published literature. Vaccine 2012;30:6347-58
- Cabezas C, Echevarria C, Gomez G, Gotuzzo E. Pilot program of immunization against viral hepatitis B, integrated in the extended immunization program in Abancay (Peru). Rev Gastroenterol Peru 1995;15(3):215-22
- Goh KT. Prevention and control of hepatitis B virus infection in Singapore. Annals Acad Med Singapore 1997;26(5):671-81
- Jiang H, Zhang M, Liang J, et al. Evaluation on immunization effect of hepatitis B vaccine of GAVI project in Fukang City, Xinjiang. Endemic Dis Bull 2010;25(2):27-8
- Chien Y-C, Jan C-F, Kuo H-S, Chen C-J. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev 2006;28:126-35
- Wenger JD, DiFabio J, Landaverde JM, et al. Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four newly adopting countries. Vaccine 1999;18:736-42
- Scheifele D. Hib conjugate vaccines: lessons learned. Int J Clin Pract 2001;118:8-9
- Bigham M, Remple VP, Pielak K, et al. Uptake and behavioural and attitudinal determinants of immunization in an expanded routine infant hepatitis B vaccination program in British Columbia. Can J Public Health 2006;97:90-5
- Salisbury DM. The introduction of Haemophilus influenza type b immunization into the United Kingdom: practical steps to assure success. Pediatr Infect Dis J 1998;17:S136-9
- Shefer A, Markowitz L, Deeks S, et al. Early experience with human papilloma virus vaccine introduction in the United States, Canada and Australia. Vaccine 2008;26:K68-75
- Salisbury D. Introduction of a conjugate meningococcal type C vaccine programme in the UK. J Paediatr Child Health 2001;37(5):S34-6
- PATH. Rotavirus disease and vaccines in Asia. Available from: www.path.org/publications/files/VAD_rotavirus_asia_fs.pdf
- BUMN. ITAGI: negative campaign against vaccine cannot be left. Available from: www.bumn.go.id/biofarma/en/publikasi/berita/itagi-kampanye-negatif-antivaksin-tidak-boleh-dibiarkan/
- Black RE, Cousens S, Johnson HL, et al. Global, regional and national causes of child mortality in 2008: a systematic review. Lancet 2010;10:1-19
- GAVI Alliance. Indonesia introduces five-in-one vaccine for children. Available from: www.gavialliance.org/library/news/press-releases/2013/indonesia-introduces-five-in-one-vaccine-for-children/
- Kim SY, Goldie SJ, Salomon JA. Cost-effectiveness of rotavirus vaccination in Vietnam. BMC Public Health 2009;9(29):1-12
- Muangchana C, Riewpaiboon A, Jiamsiri S, et al. Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand. Vaccine 2012;30:2839-47
- Carlos CC, Inobaya MT, Bresee JS, et al. The burden of hospitalizations and clinic visits for rotavirus disease in children aged <5 years in the Philippines. J Infect Dis 2009;200:S174-81
- PATH. The Philippines will begin vaccinating children against rotavirus in 2012. Available from: http://sites.path.org/rotavirusvaccine/files/2012/09/RotaFlash-January-10-2012.pdf
- IRIN. Health: Asia fails to take up rotavirus vaccine. Available from: www.irinnews.org/report/96259/health-asia-fails-to-take-up-rotavirus-vaccine
- GlaxoSmithKline Philippines. New study finds diarrhea a serious family burden. Available from: www.gsk.com.ph/Rotarix.html
- do Carmo GMI, Yen C, Cortes J, et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med 2011;8(4):1-11
- Molto Y, Cortes JE, de Oliveira LH, et al. Reduction in diarrhea-associated hospitalizations among children aged <5 years in Panama following the introduction of rotavirus vaccine. Pediatr Infect Dis J 2011;30(1):S16-20
- Orozco M, Vasquez J, Pedreira C, et al. Uptake of rotavirus vaccine and national trends of acute gastroenteritis among children in Nicaragua. J Infect Dis 2009;200:S125-30
- Patel M, Pedreira C, de Oliveira LH, et al. Duration of protection of pentavalent rotavirus vaccination in Nicaragua. Pediatrics 2012;130(2):1-8
- de Oliveira LH, Danovaro-Holliday MC, Matus CR, Andrus JK. Rotavirus vaccine introduction in the Americas: progress and lessons learned. Expert Rev Vaccines 2008;7(3):345-53
- WHO. Rotavirus vaccine and intussusception. Available from: www.who.int/vaccine_safety/committee/topics/rotavirus/rotarix_and_rotateq/Dec_2010/en/index.html
- Mahoney RT, Maynard JE. The introduction of new vaccines into developing countries. Vaccine 1999;17:646-52
- Ustrup M, Madsen LB, Bygbjerg IC, Konradsen F. Outstanding challenges for rotavirus vaccine introduction in low-income countries – a systematic review. Dan Med Bull 2011;58(10):1-5
- Breen D. Pneumococcal vaccination programme in over 65s and at-risk groups: the Dumfries and Galloway experience. Commun Dis Public Health 2003;6(3):228-30
- Henderson CE, Rich JD, Lally MA. HPV vaccination practices among juvenile justice facilities in the United States. J Adolesc Health 2010;46(5):495-8
- Yuan J, Wang M, Liang J, et al. Analysis of the vaccination program after Wenchuan earthquake in Sinchuan, 2008. J Trop Med (Guangzhou) 2008;8(8):833-5
- Griffiths UK, Korczak VS, Ayalew D, Yigzaw A. Incremental system costs of introducing combined DTwP-hepatitis B-Hib vaccine into national immunization services in Ethiopia. Vaccine 2009;27(9):1426-32
- Soares-Weiser K, Maclehose H, Ben-Aharon I, et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev 2010;5:CD008521